SHR-4597
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 25, 2025
Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma
(clinicaltrials.gov)
- P2 | N=60 | Not yet recruiting | Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
New P2 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
April 26, 2024
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic Patients
(clinicaltrials.gov)
- P1 | N=80 | Not yet recruiting | Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
New P1 trial • Asthma • Immunology • Respiratory Diseases
1 to 2
Of
2
Go to page
1